Literature DB >> 18361003

The Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. An assessment by the Australian and New Zealand intensive care society.

P Hicks, D J Cooper, S Webb, J Myburgh, I Seppelt, S Peake, C Joyce, D Stephens, A Turner, C French, G Hart, I Jenkins, A Burrell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18361003     DOI： 10.1177/0310057X0803600202

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN： 0310-057X            Impact factor:   1.669


× No keyword cloud information.
  9 in total

1.  The Surviving Sepsis Campaign's Revised Sepsis Bundles.

Authors:  Amisha V Barochia; Xizhong Cui; Peter Q Eichacker
Journal:  Curr Infect Dis Rep       Date:  2013-10       Impact factor: 3.725

2.  The Surviving Sepsis Campaign: robust evaluation and high-quality primary research is still needed.

Authors:  Simon Finfer
Journal:  Intensive Care Med       Date:  2010-01-13       Impact factor: 17.440

3.  Comparison of the accuracy of transpulmonary thermodilution measurement using indicators of different temperatures.

Authors:  Shulan Chen; Pingdong Lin; Zhenshuang Du; Fangchen Lan; Shanshan Wu; Tiegang Zhong; Xiaohua Liang; Hongyu Liu; Cuiping Zeng; Chenghua Zhang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

4.  The consistent inconsistency of fluid challenges in the ICU: We should reflect on extreme variation in our practice.

Authors:  David Gattas; Anders Åneman
Journal:  Intensive Care Med       Date:  2015-07-11       Impact factor: 17.440

5.  Steroids for sepsis: yes, no or maybe.

Authors:  Paul E Marik
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

6.  Endorsing performance measures is a matter of trust.

Authors:  Dharmvir S Jaswal; Charles Natanson; Peter Q Eichacker
Journal:  BMJ       Date:  2018-02-23

7.  Septic shock: the changing Zeitgeist of management.

Authors:  Allen C Cheng; Dianne P Stephens
Journal:  F1000 Med Rep       Date:  2009-01-21

8.  Surviving sepsis: going beyond the guidelines.

Authors:  Paul E Marik
Journal:  Ann Intensive Care       Date:  2011-06-07       Impact factor: 6.925

9.  Astragaloside IV Alleviates Lipopolysaccharide-Induced Acute Kidney Injury Through Down-Regulating Cytokines, CCR5 and p-ERK, and Elevating Anti-Oxidative Ability.

Authors:  Wei Zhou; Yi Chen; Xingyu Zhang
Journal:  Med Sci Monit       Date:  2017-03-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.